ProShares UltraLeveraged EquityCRCA · NYSE Arca

ProShares Ultra CRCL (CRCA)

Compare Leveraged & Inverse ETFs Compare with others

Price: $22.35; —11 Sept 2026
Assets: —; Total net assets
Expense ratio: —; Per year
Yield: —; Trailing distributions

1Y return: -85.2%-117.5%; Category 32.3%
3Y CAGR: —; Category 25.3%
5Y CAGR: —; Category 6.1%

Loading NAV history…

ProShares Ultra CRCL

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	+47.8%	+4.8%	-66.2%	-43.9%	-85.2%	—	—	—	-87.6%
Leveraged Equity average	-3.1%	-7.2%	21.2%	13.2%	32.3%	25.3%	6.1%	9.5%	-5.3%
Difference	+50.9%	+12.0%	-87.4%	-57.1%	-117.5%	—	—	—	-82.3%

Holdings

This ETF publishes no holdings breakdown.

ETF details

Issuer: ProShares Ultra
Category: Equity · Leveraged Equity
Ticker: CRCA
Exchange: NYSE Arca
Inception: 7 Aug 2025 (1.1 years)
Structure: Exchange traded fund
Expense ratio: —
Distribution yield: —
Total net assets: —

Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other leveraged equity ETFs

Other ETFs in the Leveraged Equity category.

Compare Leveraged & Inverse ETFs